市場調查報告書
商品編碼
1463585
北美牛隻診斷市場預測至 2030 年 - 區域分析 - 按產品、疾病類型和最終用戶(獸醫醫院、獸醫診所和其他最終用戶)North America Bovine Diagnostics Market Forecast to 2030 - Regional Analysis - by Product, Disease Type, and End User (Veterinary Hospitals, Veterinary Clinics, and Other End-Users) |
北美牛隻診斷CAGR預計將從2022年的4.4382億美元成長到2030年的7.6888億美元。
牛乳房炎的高盛行率和經濟影響推動了北美牛隻診斷市場
牛乳腺炎是一個全球性問題,對全球農業部門帶來巨大的經濟損失。乳腺炎會導致受影響動物的產奶量下降,並導致持續的獸醫費用,從而導致酪農的獲利能力下降。根據賽默飛世爾科技 2022 年 7 月發布的估計,乳腺炎每年對全球乳製品行業造成的總成本在 197 億美元至 320 億美元之間。光是在美國,每年因亞臨床乳房炎造成的費用預計就超過 10 億美元。因此,需要持續監測和風險分析,以防止造成巨大的經濟損失。
根據2021 年4 月發表的研究《全球和全國範圍內乳牛和水牛亞臨床和臨床乳房炎盛行率的系統性回顧和統合分析》,全球亞臨床乳房炎(SCM) 和臨床乳房炎(CM) 的匯總盛行率2011-2019 年期間分別為 42% 和 15%。由於乳製品行業中乳腺炎的歷史較長,預計乳腺炎的盛行率將會增加。來自世界各地的事實和資料表明臨床乳房炎的高盛行率,這引發了對牛診斷的需求。此外,不同國家政府引入的監測計劃和良好的管理系統支持了牛隻診斷市場。
北美牛隻診斷市場概況
北美的牛隻診斷市場分為美國、加拿大和墨西哥。美國在區域和全球市場中佔最大佔有率。預計加拿大和墨西哥的牛隻診斷市場在預測期內將以快速複合年成長率成長。北美市場的成長歸因於產品發布和政府措施數量的增加以及診斷技術的持續發展。美國的牛隻診斷市場受益於政府不斷增加的控制人畜共通傳染病、乳房炎和結核病的力度。獸醫診斷的不斷發展導致牛隻診斷產品的頻繁推出。 2022年10月,堪薩斯州立大學獸醫學院堪薩斯州獸醫診斷實驗室開發出一種檢測方法,可檢測牛隻的兩種主要血源性疾病。堪薩斯州獸醫診斷實驗室的研究人員開發了一種聚合酶鏈反應 (PCR) 技術來檢測地方性無形體病和新出現的泰勒蟲病。這項測試將使獸醫和養牛戶能夠診斷牛群是否存在致病微生物,並幫助他們有效預防和控制疾病。 2023 年 6 月,Neogen 公司推出了 Igenity BeefXDairy。這是一種針對乳牛犢的新型基因組測試。 Igenity BeefXDairy 提供一些關鍵性狀的見解,包括胴體質量、平均日增重和 Igenity 終端指數。這些見解有助於犢牛生產者向潛在買家推銷他們的牛隻。
北美牛隻診斷市場收入及 2030 年預測(百萬美元)
北美牛隻診斷市場細分
北美牛隻診斷市場按產品、疾病類型、最終用戶和國家細分。
根據產品,北美牛隻診斷市場分為免疫測定試劑盒、PCR 試劑和試劑盒、血凝抑制 (HI) 測定和其他產品。 2022 年,免疫檢測試劑盒細分市場佔據北美牛隻診斷市場的最大佔有率。
根據疾病類型,北美牛診斷市場分為牛病毒性腹瀉(BVD)、牛結核病(TB)、牛乳房炎、口蹄疫(FMD)和其他疾病類型。 2022 年,牛乳房炎細分市場佔據北美牛隻診斷市場的最大佔有率。
根據最終用戶,北美牛隻診斷市場分為獸醫醫院、獸醫診所和其他最終用戶。 2022 年,獸醫院細分市場佔據北美牛隻診斷市場的最大佔有率。
根據國家/地區,北美牛隻診斷市場分為美國、加拿大和墨西哥。 2022 年,美國將主導北美牛隻診斷市場。
bioMerieux SA、Idex Laboratories Inc、Innovative Diagnostics SAS、Neogen Corp 和 Thermo Fisher Scientific Inc 是北美牛隻診斷市場上的一些領先公司。
The North America bovine diagnostics market is expected to grow from US$ 443.82 million in 2022 to US$ 768.88 million by 2030. It is estimated to grow at a CAGR of 7.1% from 2022 to 2030.
High Prevalence and Economic Impact of Bovine Mastitis Fuels North America Bovine Diagnostics Market
Bovine mastitis is a global concern that incurs huge economic losses to the global agriculture sector. Mastitis results in lowered milk production in affected animals and causes continuous veterinary expenses, resulting in reduced profitability for dairy farmers. According to the estimates published by Thermo Fisher Scientific in July 2022, the total annual cost to the global dairy industry caused by mastitis is between US$ 19.7 billion to US$ 32 billion. In the US alone, the cost of subclinical mastitis is expected to exceed US$ 1 billion annually. Therefore, continuous monitoring and risk analysis are required to prevent huge economic losses.
According to the study "Global and countrywide prevalence of subclinical and clinical mastitis in dairy cattle and buffaloes by systematic review and meta-analysis," published in April 2021, the global pooled prevalence of subclinical mastitis (SCM) and clinical mastitis (CM) were 42% and 15%, respectively, during 2011-2019. The prevalence of mastitis is expected to increase due to the prolonged history of the disease in the dairy industry. The facts and data from across the world indicate the high prevalence of clinical mastitis, which triggers the demand for bovine diagnostics. Moreover, surveillance programs and good management systems introduced by governments in different countries support the bovine diagnostics market.
North America Bovine Diagnostics Market Overview
The bovine diagnostics market in North America is segmented into the US, Canada, and Mexico. The US accounts for the largest share of the regional and global market. The bovine diagnostics market in Canada and Mexico is anticipated to grow at fast CAGRs during the forecast period. The market growth in North America is attributed to the increasing number of product launches and government initiatives, and ongoing developments in diagnostics technologies. The bovine diagnostics market in the US is benefitted from rising government efforts to control zoonotic diseases, mastitis, and tuberculosis. Continuous developments in veterinary diagnostics result in frequent bovine diagnostics product launches. In October 2022, the Kansas State Veterinary Diagnostic Laboratory of the Kansas State University College of Veterinary Medicine developed a test to detect two major blood-borne diseases in cattle. Researchers at Kansas State Veterinary Diagnostic Laboratory developed a polymerase chain reaction (PCR) technique to detect endemic anaplasmosis and emerging Theileriosis. The test will allow veterinarians and cattle farmers to diagnose the herds with disease-causing microorganisms and help them effectively prevent and manage the diseases. In June 2023, Neogen Corporation launched Igenity BeefXDairy. It is a novel genomic test for beef-on-dairy calves. Igenity BeefXDairy provides insights about some key traits, including carcass quality, average daily gain, and the Igenity Terminal Index. These insights help calf producers to market their cattle to potential buyers.
North America Bovine Diagnostics Market Revenue and Forecast to 2030 (US$ Million)
North America Bovine Diagnostics Market Segmentation
The North America bovine diagnostics market is segmented into product, disease type, end user, and country.
Based on product, the North America bovine diagnostics market is segmented into immunoassay kits, PCR reagents & kits, hemagglutination inhibition (HI) assay, and other products. The immunoassay kits segment held the largest share of the North America bovine diagnostics market in 2022.
Based on disease type, the North America bovine diagnostics market is segmented into bovine viral diarrhea (BVD), bovine tuberculosis (TB), bovine mastitis, foot and mouth disease (FMD), and other disease types. The bovine mastitis segment held the largest share of the North America bovine diagnostics market in 2022.
Based on end user, the North America bovine diagnostics market is segmented into veterinary hospitals, veterinary clinics, and other end-users. The veterinary hospitals segment held the largest share of the North America bovine diagnostics market in 2022.
Based on country, the North America bovine diagnostics market is segmented int o the US, Canada, and Mexico. The US dominated the North America bovine diagnostics market in 2022.
bioMerieux SA, Idexx Laboratories Inc, Innovative Diagnostics SAS, Neogen Corp, and Thermo Fisher Scientific Inc are some of the leading companies operating in the North America bovine diagnostics market.